Semaglutide Supply Expansion
1 ticker uses this canonical theme · 1 high confidence
Unclustered (1)
| Ticker | Conf. | Primary theme | Sub-industry |
|---|---|---|---|
| NVO | high | GLP-1 Obesity Drug Leader Leading the GLP-1 obesity market with Wegovy and Ozempic, but facing generics and competition from Eli Lilly. | — |
★ = primary thesis · click ticker for full detail · cluster grouping reflects the latest cluster snapshot.